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Abstract
Background: Intramuscular lipoma is a relatively common benign neoplasm that is occasionally
described as an infiltrating lipoma. Typical benign tumors show a clear margin, however, the
infiltrative growth pattern of this lipoma mimics that of a malignant tumor. Although its growth has
an effect on muscle bundles and it is known to never metastasize, the mechanism of infiltrative
growth is not well understood. Previously, little attention has been paid to pathogenic features of
muscle fibers around an intramuscular lipoma.
Methods: In the present study, we focused on pathologic changes of the surrounding skeletal
muscles especially to the degenerative features of involving muscular types, and evaluate the role
of type-selective muscular degeneration for the infiltrative growth of intramuscular lipomas.
Following a review of the medical records in our institute, 17 lesions containing muscle tissues in
their specimens (15 infiltrating lipomas, 2 well-circumscribed lipomas) were analyzed
immunohistochemically. The tumor from the most recent case was also subjected to
ultrastructural analysis. Two cases of the traumatic muscle damage were also evaluated as the
control experiments.
Results:  These analyses revealed type-selective muscle involution in 11 of 17 intramuscular
lipomas and in 10 of 11 of the infiltrative type, with an involving pattern that resembled that of a
neurogenic or myogenic disorder. Immunoreactivity to cathepsin-D, a lysosomal catabolic enzyme,
was increased in the involved muscle fibers. Subsarcolemmal vacuoles in the muscle fibers of the
peripheral areas were also positive for cathepsin-D, while degenerative findings were not visually
apparent in these areas. Ultrastructural analysis revealed degenerative changes in those fibers.
Neither positive staining for cathepsin-D nor type-selective atrophy was detected in the sections
of traumatic muscle damage.
Conclusions: Our findings suggest that type-selective muscular degeneration and endomysial fatty
growth as a result of atrophy may modulate the infiltrating growth characteristic of intramuscular
lipoma.
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Background
An intramuscular lipoma is a relatively common benign
neoplasm that causes concern for both clinicians and
pathologists, because of its large size, deep location, and
infiltrating growth, which has led to its description as an
infiltrating lipoma. Typically benign tumors show a clear
margin, however, the infiltrative growth pattern of this
tumor mimics that of a malignant one. Further, its growth
has an effect on the numbers of muscle bundles, though it
never metastasizes. The mechanisms of their infiltrative
growth are not fully understood, although it has been
reported a possible role of aberrant high mobility group
proteins (HMGs) during the development of lipomatous
tumors [1,2]. Excessive endomysial fatty growth is not
always induced by a true neoplastic condition, however, it
could also develop as a result of muscle damage [3,4]. Pre-
viously, little attention has been paid to pathogenic fea-
tures of muscle fibers around an intramuscular lipoma
and the surrounding muscle changes have not been eluci-
dated. In the present study, we focused on pathologic
changes of the surrounding skeletal muscle fibers in intra-
muscular lipomas, especially to the degenerative features
of involving muscular types. We evaluate the role of type-
selective muscular degeneration for the infiltrative growth
of intramuscular lipomas using immunohistological
analyses.
Methods
Following a review of the medical records in our institute,
surgically and histologically proven intramuscular lipo-
mas were selected, and representative formalin-fixed and
paraffin-embedded tissue sections from 22 cases were
stained with hematoxylin-eosin (H-E). Two cases of the
traumatic muscle damage were also evaluated as the con-
trol experiments.
Immunohistochemical analysis
Seventeen lesions containing muscle tissues in their spec-
imens (15 infiltrating lipomas, 2 well-circumscribed lipo-
mas) were used. Characters of lipomas were summarized
in Table 1. Consecutive tissue sections were incubated
with antibodies against troponin T (NCL-TROPT, 1:20;
Novocastra Lab. Ltd., Newcastle, UK), sarcoplasmic or
endoplasmic reticulum Ca2+ ATPases (SERCA) 1, (NCL-
SERCA1, 1:100; Novocastra), SERCA2 (NCL-SERCA2,
1:100; Novocastra), cathepsin-D (rabbit antiserum,
1:100; DAKO, Glostrup, Denmark), and MAC387
(DSKO-MAC387, 1:100; DAKO), after which they were
subjected to staining using a streptavidin-biotin-peroxi-
dase complex method. Prior to troponin T- and MAC387-
immunostaning, tissue sections were treated with 0.1%
trypsin in 0.2% calcium chloride for 15 minutes at 37°C,
following deparaffinization. NCL-TROPT antibody
against to troponin T reacts with fast muscle troponin, but
not slow muscle troponin T [5]. The SERCA are the ATP
Table 1: Immunohistochemical analysis of intramuscular lipomas.
Case Age (year) Gender Location Histological type Atrophic muscle fiber* Cathepsin-D
1 57 M sternocleidomastoideus infiltrative slow-dominant atrophy +
2 65 M rectus femolis infiltrative slow-dominant atrophy +
3 48 M adductor longus infiltrative slow-dominant atrophy +
4 43 M vastus medialis infiltrative slow-dominant atrophy +
5 71 M trapezius infiltrative slow-dominant atrophy + +
6 64 F vastus lateralis infiltrative fast-dominant atrophy + +
7 71 F tensor fascia lata infiltrative fast-dominant atrophy +
8 37 F deltoideus infiltrative fast-dominant atrophy +
9 47 F latissimus dorsi infiltrative fast-dominant atrophy + +
10 66 F deltoideus infiltrative fast-dominant atrophy + +
11 48 F vastus medialis infiltrative non-dominant atrophy + +
12 59 F brachioradialis infiltrative non-dominant atrophy +
13 51 F vastus medialis infiltrative non-dominant atrophy +
14 43 F longissimus thoracics infiltrative non-dominant atrophy + +
15 49 M sartorius infiltrative non-dominant atrophy + +
16 15 F rectus femolis well-circumscribed slow-dominant atrophy +
17 54 F levator scapulae well-circumscribed non-dominant atrophy +
18 3 M paravertebral muscle well-circumscribed - -
19 57 F sartorius well-circumscribed - -
20 43 F rhomboideus well-circumscribed - -
21 21 F hypotener well-circumscribed - -
22 51 M rectus femolis well-circumscribed - -
*: Immunohistochemical evaluation using troponin T and SERCA -: Impossible specimens to evaluate immunohistochemically because of no muscle 
tissue +: Involving muscle tissues are positive to cathepsin-D. ++: Muscle tissues are stained with cathepsin-D around small fatty vacuoles or nuclear 
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dependent calcium pumps in intracellular organelles that
are responsible in part for the maintenance of low cyto-
plasmic free Ca2+ ion concentrations [6]. The SERCA1
gene is exclusively expressed in type II (fast) skeletal mus-
cle, while SERCA2 isoform expressed mainly in type I
(slow) skeletal muscle. NCL-SERCA1 and NCL-SERCA2 is
useful in experiment measuring the time course of transi-
tion from the fast to the slow isoform of the Ca2+ ATPases.
Accordingly, type-selective muscle staining was available
using these antibodies.
Ultramicroscopic analysis
The tumor from the most recent case, case 11 (Table 1),
was also subjected to ultrastructural analysis. The speci-
men was fixed in 2.5% glutaraldehyde, post-fixed in 1%
OsO4, and embedded in Epon 812. The sections were
stained with uranyl acetate and lead citrate, and then
examined with a JEM-1200EX II electron microscope
(JEOL Ltd. Tokyo, Japan).
Results
No atypical feature was detected in any tumor cells of the
specimens. Tumor tissues showed infiltration in 15 cases
and lipocytes were admixed with skeletal muscle fibers in
various ratios. In 2 out of the other 7 cases, the tumors
were composed entirely of lipocytes and skeletal muscle
tissue was seen in the surrounding area. Macroscopically,
all of these 7 cases were well demarcated from their sur-
rounding tissues. Accordingly, the former group of 15
tumors was classified as the infiltrative type, and the latter
7 as the well-circumscribed type, according to the classifi-
cation of Fletcher and Martin-Bates [7]. In the infiltrative
type, fatty cells had grown in the endomysial space, how-
ever, some of the muscle fibers in the tumor were spared,
though they showed extensive damage. Various degrees of
degenerative changes including sarcoplasmic mass and
subsarcolemmal vacuolar changes were found in the mus-
cle fibers, though focal necrosis or opaque fibers were not
detected. A saw-tooth like appearance due to compression
by the fatty cells was also detected. Further, markedly thin
atrophic or involutional muscle fibers were seen, how-
ever, they were not always grouped, while split fibers were
shown in some cases. Nuclear swelling, central nuclei, or
nuclear chains were detected in the atrophic and/or
degenerative fibers (Fig. 1).
Immunohistochemical analyses using SERCA and tro-
ponin T revealed type-selective muscle fiber atrophy or
involution in 11 of 17 cases. Of these, 5 lesions had type
II (fast) dominant atrophy and type I (slow) dominant
was revealed in 6 cases, while in the remaining 6 cases,
type-selective change was not found (Table 1). Type-selec-
tive atrophy was not confined to the areas with fatty cell
growth, but was also found in peripheral areas where fatty
cell growth was not prominent (Figs. 2A,2B,2C). Further,
cathepsin-D was found in muscle fibers undergoing
degenerative change and immunoreactivity for this lyso-
somal enzyme was diffusely distributed in some fibers,
while focal subsarcolemmal staining was revealed in oth-
ers. Subsarcolemmal vacuoles in the muscle fibers of the
peripheral areas were positive for cathepsin-D (Fig. 3),
while degenerative findings were not visually apparent in
these areas. More severely degenerative findings like seg-
mental necrosis or opaque fibers were not microscopically
demonstrated. Monocytes/macrophages positive for Mac
387 were detected in 12 cases, though they were located in
the perivascular spaces and myophagia change was not
observed. Neither positive staining for cathepsin-D nor
type-selective atrophy was detected in the sections of trau-
matic muscle damage (Figs. 4A,4B,4C).
The ultrastructural analysis revealed endomysial fatty cell
growth and an increase of mononuclear cells with small
vacuoles in the endomysial portions. Mitochondria were
occasionally accumulated in subsarcolemmal protein and
lysosomes increased in the sarcoplasm (Fig. 5A), and their
distribution was consistent with the immunoreactivity to
anti-cathepsin-D. Further, Z-Disc loss and an increase of
mitochondria were observed in some of the degenerative
fibers, with glycogen abundantly accumulated (Fig. 5B)
and satellite cells increased in these muscle fibers.
However, focal contraction or necrosis was not observed.
Unfortunately, nerve lesions were not evaluated, because
there were no terminal motor nerve fibers or neuromuscu-
lar junctions included in the specimens.
Intramuscular lipoma specimen Figure 1
Intramuscular lipoma specimen. Various degrees of muscle 
atrophy, as well as pyknotic nuclei or nuclear swelling, shown 
in the specimen (hematoxylin-eosin stain, ×200).BMC Musculoskeletal Disorders 2004, 5 http://www.biomedcentral.com/1471-2474/5/20
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Discussion
A lipoma is the most common type of soft tissue tumor
and solitary lipomas have been classified into two types;
cutaneous/superficial and deep-seated/subfascial. In spite
of some descriptions about superficial lipomas [8], little is
known about the etiology or histogenesis of intramuscu-
lar lipomas, which are the deep-seated type. Intramuscu-
lar and intermuscular lipomas are relatively rare as
compared to superficial lipomas, and have been reported
to comprise 1.8% and 0.3% of all fatty tumors, respec-
tively [9]. Microscopically, an intramuscular lipoma is
composed of mature lipocytes, the same as lipomas found
in other areas. Macroscopically, intramuscular lipomas
are not always as well circumscribed as the superficial type
and such cases have been designated as infiltrating lipo-
mas. Fletcher and Martin-Bates noted that an intramuscu-
lar lipoma could also be subdivided into infiltrative and
well-circumscribed types [7], however, the factors contrib-
uting to these variations are not well understood.
Fat cell overgrowth due to muscular damage is not
uncommon and has been reported in several orthopedic
diseases such as muscular dystrophy [10] and rheumatoid
arthritis [11], as well as other joint diseases and various
neuropathies [3]. The present study was performed to
investigate the association between lipomatous cell
growth and surrounding muscular degeneration in intra-
muscular lipomas, and evaluate the contribution of focal
muscular atrophy to the infiltrating growth of these
tumors.
Immunohistochemical study for the involving muscle fibers Figure 2
Immunohistochemical study for the involving muscle fibers. 
(A) SERCA1-positive fast muscle tissues are dominantly pre-
served, with the other type prominently decreased (×125). 
(B) Slow muscle fiber tissues reacting to SERCA2 are con-
served, and SERCA2-negative fibers are smaller and angu-
lated (×125). (C) Fast muscle tissues stained by troponin T 
are shown dominantly atrophic and replaced with fatty tis-
sues (×125).
Cathepsin-D immunohistochemical study Figure 3
Cathepsin-D immunohistochemical study. Muscle regions 
developed sequentially from small subsarcolemmal vacuoles 
are positive for cathepsin-D (×250).BMC Musculoskeletal Disorders 2004, 5 http://www.biomedcentral.com/1471-2474/5/20
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Interestingly, type-selective muscle fiber atrophy or
degenerative change was found in 70% of the present
tumors (11/17 cases), most of which (10/11 case) were
the infiltrating type. Type-selective muscle involvement in
these 11 cases strongly suggests that they have had any
neurogenic or myogenic disorders, [4] at the focal lesions,
and endomysial fat overgrowth could be explained as a
result of muscle involution. Type-selectivity was not the
same in these 11 cases and the fundamental disease mech-
anism seems to be heterogeneous. Further, increases of
immunoreactivity to cathepsin-D, a lysosomal catabolic
enzyme, was corresponded to the degree of degenerative
or atrophic changes in these specimens, and ultrastruc-
tural analysis also revealed degeneration in the surround-
ing muscle fibers of the lesion.
The main factor determining the differences in muscle
pathology between the various disorders is the time
Histological analyses for the traumatic muscle damage Figure 4
Histological analyses for the traumatic muscle damage. (A) 
No atypical finding was demonstrated in the specimen 
(hematoxylin-eosin stain, ×100). In the immunohistochemical 
study, neither type-selective atrophy in SERCA1 (×100) (B) 
nor positive staining for cathepsin-D (×200) (C) was 
detected in the specimens.
Ultrastructural study Figure 5
Ultrastructural study. (A) Mitochondria are shown increased 
in the sarcoplasm (×4000). (B) Glycogen is abundantly accu-
mulated in degenerated muscle fibers (×4000).Publish with BioMed Central    and   every 
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course, and chronic or longstanding disorders offer more
opportunity various histological aspects than those that
are rapidly progressive. The relatively big size and the
longstanding of the intramuscular lipomas might be pro-
moting disuse atrophy in the surrounding muscle fibers,
and rarely muscle type-selective atrophy. An intramuscu-
lar lipoma itself may cause the surrounding muscle atro-
phy due to compressive growth, but such a case of muscle
atrophy will often likely be presented without muscle
types-selectivity. Neither cathepsin-D reactivity nor mus-
cle types-selectivity was found in the control sections of
our study, i.e., traumatic muscles. Our immunohisto-
chemical analyses revealed type-selective muscular atro-
phy in a majority of the present intramuscular lipomas,
suggesting any association of focally neurogenic or myo-
genic disorders in the lesions. Ultrastructural analysis
revealed degenerative findings of the surrounding muscle,
but could not demonstrate any specific findings involved
with neurogenic or myogenic disorders. Patterns in the
involved muscle fibers in the intramuscular lipomas
could be divided into different groups and it was presum-
able that pathogenic mechanisms of the involved muscu-
lar degeneration were heterogeneous. As a results of these
focally muscular atrophy, the endomysial fatty over
growth in the involving muscles could modulate the infil-
trating growth of an intramuscular lipoma into the sur-
rounding muscular tissues. In the present study, surgically
and histologically proven intramuscular lipomas were
analyzed, and only one case was available to evaluate
ultrastructurally. Unfortunately, neuromuscular junction
or nerve bundles were not included in the ultrastructural
specimens, and the involvement of neurogenic factors
with the pathogenesis could not be estimated. In a future
report, the primary cause of focal muscle involution
should be made clearly.
Conclusions
The findings of the present study suggest that type-selec-
tive muscular degeneration and endomysial fatty growth
as a result of focal atrophy may modulate the infiltrating
growth characteristic of intramuscular lipoma.
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